Dr. Waldrop is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
555 S 18th St
Columbus, OH 43205Phone+1 614-722-6200
Summary
- Dr. Megan Waldrop is a Child Neurologist in Columbus, OH and is affiliated with Nationwide Children's Hospital. She received her medical degree from Albany Medical College and has been in practice 6 years. She specializes in neuromuscular medicine and gene therapy. She is sponsor investigator on two first in human gene therapy studies and is also working to increase equitable access to expensive genetic therapies. She has more than 30 publications and over 400 citings.
Education & Training
Ohio State University HospitalFellowship, Neuromuscular Medicine (Neurology), 2016 - 2017
University of California (Irvine)Residency, Child Neurology, 2011 - 2016
Albany Medical CollegeClass of 2011
Certifications & Licensure
CA State Medical License 2012 - Present
OH State Medical License 2016 - 2025- American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
- American Board of Psychiatry and Neurology Neuromuscular Medicine
Clinical Trials
- Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA) Start of enrollment: 2018 Sep 25
Publications & Presentations
PubMed
- 1 citationsClinical decision making around commercial use of gene and genetic therapies for spinal muscular atrophy.Megan A Waldrop
Neurotherapeutics. 2024-07-01 - 1 citationsLong-Term Follow-Up Cares and Check Initiative: A Program to Advance Long-Term Follow-Up in Newborns Identified with a Disease through Newborn Screening.Mei Lietsch, Kee Chan, Jennifer Taylor, Bo Hoon Lee, Emma Ciafaloni
International Journal of Neonatal Screening. 2024-04-18 - 1 citationsIncrease in Full-Length Dystrophin by Exon Skipping in Duchenne Muscular Dystrophy Patients with Single Exon Duplications: An Open-label Study.Stefan Nicolau, Jyoti Malhotra, Maryann Kaler, Pamela Magistrado-Coxen, Megan A Iammarino
Journal of Neuromuscular Diseases. 2024-01-01
Press Mentions
Ohio Study Finds Zolgensma Safe, Effective, Particularly in Younger InfantsAugust 31st, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
